Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Here are the data-based reference points for Mounjaro: In the pivotal 72-week trial of tirzepatide in adults with obesity, participants lost an average of about 15.0% (5 mg dose), 19.5% (10 mg), and 20.9% (15 mg) of their body weight
Our patients who diligently adopt recommended lifestyle changes tend to keep the pounds off once they quit taking GLP-1
Weight gain is often influenced by a combination of factors, including calorie intake, hormonal regulation, physical activity levels, and underlying medical conditions
Tirzepatide is primarily used to treat the following conditions: Type 2 Diabetes: By improving insulin sensitivity and reducing blood sugar levels, Tirzepatide helps manage type 2 diabetes effectively
